Appili Therapeutics Inc. (TSX:APLI)
Canada · Delayed Price · Currency is CAD 0.0200
-0.0050 (-20.00%)
At close: Feb 9, 2026
Appili Therapeutics Market Cap
Appili Therapeutics has a market cap or net worth of CAD 2.57 million as of February 9, 2026. Its market cap has decreased by -39.51% in one year.
Market Cap
2.57M
Enterprise Value
14.44M
Revenue
199.69K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since June 25, 2019, Appili Therapeutics's market cap has decreased from 26.83M to 2.57M, a decrease of -90.43%. That is a compound annual growth rate of -29.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 2.57M | -20.00% |
| Dec 29, 2025 | 3.21M | -24.39% |
| Dec 30, 2024 | 4.24M | - |
| Dec 29, 2023 | 4.24M | -22.22% |
| Dec 30, 2022 | 5.46M | -33.42% |
| Dec 31, 2021 | 8.20M | -89.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Restart Life Sciences | 5.94M |
| Aptose Biosciences | 5.69M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| Gemina Laboratories | 4.59M |
| XORTX Therapeutics | 4.04M |
| MindBio Therapeutics | 3.84M |
| Rakovina Therapeutics | 3.07M |